01 / UNDERSTAND
Understand the science
Clarify how the product works, where uncertainty remains, and which questions have the greatest impact on development.
Independent regulatory strategy · Advanced therapies
Turning complex science into forward motion.
Gene Therapy Partners helps advanced-therapy teams resolve the regulatory, CMC, and development questions that can slow programs down—so the next decision is clearer, better supported, and easier to execute.
Our approach
Big questions. Practical answers.
We work where science, regulatory expectations, and real-world execution meet—helping teams turn complex information into a development strategy they can act on.
02 / ALIGN
Build the strategy
Connect product understanding with the evidence, quality framework, and regulatory pathway needed for the next stage.
03 / EXECUTE
Move forward
Translate strategy into decisions, agency interactions, and practical plans that support progress over time.
What we do
Regulatory and development expertise, connected.
Our work spans the scientific, manufacturing, and regulatory questions that shape advanced-therapy development.
01 / REGULATORY STRATEGY
Development pathways & agency engagement
Regulatory roadmaps, health-authority interactions, expedited development considerations, and submission strategy from early planning through registration.
02 / ADVANCED THERAPIES
Modality-specific insight
Scientific and regulatory perspectives across gene and cell therapies, viral and non-viral delivery, gene editing, and other emerging therapeutic approaches.
03 / CMC & QUALITY
Manufacturing evolution
Product understanding, control strategies, comparability, technology transfer, and quality considerations as processes evolve toward reliable commercial platforms.
04 / STRATEGIC ADVISING
Clear decisions at critical moments
Independent review of development plans, cross-functional problem-solving, and executive-level support when scientific and regulatory choices intersect.
When we help
Best suited to programs where the path is not obvious.
We work with biotechnology companies, investors, academic teams, and development partners facing decisions that require both scientific depth and regulatory judgment.
Typical engagements begin when a team needs to pressure-test a development strategy, prepare for a consequential health-authority interaction, navigate a manufacturing change, or decide what evidence is truly needed to advance.
The goal is not to add another layer of process. It is to identify the few issues that matter most, make tradeoffs explicit, and create a path the team can execute.
Connect
Working through a difficult development question?
Bring us the hard question. We can help frame the issue, identify the regulatory and development implications, and turn it into a practical next step.